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The mechanisms involved in the reprogramming of differentiated cells into induced pluripotent stem (iPS) cells by the three transcription factors Oct4 (also known as Pou5f1), Klf4 and Sox2 remain poorly understood 1 . The Ink4/Arf locus comprises the Cdkn2a-Cdkn2b genes encoding three potent tumour suppressors, namely p16
Ink4a
, p19
Arf and p15
Ink4b
, which are basally expressed in differentiated cells and upregulated by aberrant mitogenic signals [2] [3] [4] .
Here we show that the locus is completely silenced in iPS cells, as well as in embryonic stem (ES) cells, acquiring the epigenetic marks of a bivalent chromatin domain, and retaining the ability to be reactivated after differentiation. Cell culture conditions during reprogramming enhance the expression of the Ink4/Arf locus, further highlighting the importance of silencing the locus to allow proliferation and reprogramming. Indeed, the three factors together repress the Ink4/Arf locus soon after their expression and concomitant with the appearance of the first molecular markers of 'stemness'. This downregulation also occurs in cells carrying the oncoprotein large-T, which functionally inactivates the pathways regulated by the Ink4/Arf locus, thus indicating that the silencing of the locus is intrinsic to reprogramming and not the result of a selective process. Genetic inhibition of the Ink4/Arf locus has a profound positive effect on the efficiency of iPS cell generation, increasing both the kinetics of reprogramming and the number of emerging iPS cell colonies. In murine cells, Arf, rather than Ink4a, is the main barrier to reprogramming by activation of p53 (encoded by Trp53) and p21 (encoded by Cdkn1a); whereas, in human fibroblasts, INK4a is more important than ARF. Furthermore, organismal ageing upregulates the Ink4/Arf locus 2, 5 and, accordingly, reprogramming is less efficient in cells from old organisms, but this defect can be rescued by inhibiting the locus with a short hairpin RNA. All together, we conclude that the silencing of Ink4/Arf locus is rate-limiting for reprogramming, and its transient inhibition may significantly improve the generation of iPS cells.
The Ink4/Arf tumour suppressor locus encodes three important tumour suppressors (p16  Ink4a and p19 Arf from Cdkn2a, and p15
Ink4b from Cdkn2b; see scheme in Supplementary Fig. 1 ) that activate two critical anti-proliferative pathways, namely, the Rb and p53 pathways, the activation of which prevents the propagation of aberrant cells, either by apoptosis or by senescence (see scheme in Supplementary  Fig. 1 ) 4 . In brief, the paralogues p16 Ink4a and p15 Ink4b bind and inhibit the cyclin-D-dependent kinases Cdk4 and Cdk6, which in turn are important to relieve the cell-cycle inhibitory activity of the Rb tumour suppressor. On the other hand, p19
Arf binds and inhibits Mdm2, which is the main destabilizing enzyme of the tumour suppressor p53. Given the relevance of the Ink4/Arf locus in cancer protection, it is important to understand its behaviour after reprogramming in relation to the 'safety' of iPS cells.
We began by measuring the expression levels of the three genes present in the locus (Ink4a, Arf, Ink4b) in the parental mouse embryo fibroblasts (MEFs), in the resulting iPS cells after threefactor-reprogramming, and in ES cells. The transcripts of the three genes of the locus were significantly repressed in iPS/ES cells compared to MEFs (Fig. 1a) . In accordance with a previous report 1 , we observed a similar reduction in the levels of p21 in iPS/ES cells, whereas the stemness markers Nanog and Esg1 (also known as Dppa5a) were abundantly expressed (Fig. 1a) . To understand the epigenetic basis of the silencing of the locus in iPS/ES cells, we first examined the DNA methylation of the Ink4a promoter in iPS/ES Arf in a teratoma developed by a chimaericiPS-cell mouse and detected by immunohistochemistry.
cells, but there was no evidence of promoter methylation (Supplementary Fig. 2 ). When histone marks were examined by chromatin immunoprecipitation (ChIP), we found that the repressive mark histone H3 lysine 9 trimethylation (H3K9me3) essentially disappeared in iPS/ES cells compared to MEFs (Fig. 1b) . In the case of the Ink4a promoter, the repressive mark H3K27me3 also decreased, whereas the active mark H3K4me3 was increased (Fig. 1b) . Although none of the histone marks taken alone explain the silencing of the locus, when taken together they are reminiscent of the silent chromatin configuration characteristic of ES cells and known as 'bivalent' in which repressive (H3K27me3) and active (H3K4me3) marks coexist in the same molecule [6] [7] [8] . Bivalent chromatin has been proposed to be present at the Ink4/Arf locus in ES cells 9 , and to directly assess this, we performed sequential ChIP assay pulling down first H3K27me3 and then H3K4me3. We found that the Ink4a and Arf promoters are bivalent in iPS/ES cells ( Fig. 1b ; positive and negative controls are shown in Supplementary Fig. 3 ). About half of the bivalent domains in ES cells are associated with binding sites for Oct4, Sox2 or Nanog 6 . However, we could not detect the binding of these proteins, nor of Klf4, to the three promoter regions of the Ink4/Arf locus ( Supplementary Fig. 4 ). To test the functionality of the Ink4/Arf locus in iPS cells, we tested whether the locus is normally re-expressed after differentiation. Addition of retinoic acid and removal of leukaemia inhibitory factor (LIF) 10 resulted in a similar pattern of re-expression of the locus in iPS and ES cells (Fig. 1c) . As another proof of the functionality of the locus, we observed re-expression of p19
Arf in a teratoma spontaneously developed by an iPS-chimaeric mouse (Fig. 1d) . Together, these results indicate that the Ink4/Arf locus is epigenetically reprogrammed in iPS cells, adopting a bivalent, silent, configuration and retaining its ability to be re-expressed upon differentiation.
Culture conditions in vitro generally entail mitogenic hyperstimulation, which in most primary cells results in upregulation of the Ink4/ Arf locus 11 . Detailed kinetic analyses indicated that the locus is highly induced merely by the culture conditions used for reprogramming (that is, in the absence of the three factors or 'mock') ( Fig. 2a, b) . Notably, the upregulation of the locus is prevented by the presence of the three factors, and this is clearly noticeable as early as days 4-5 ( Fig. 2b and Supplementary Fig. 5 ). In contrast, single factors or double combinations only partially prevented the induction of the locus ( Supplementary Fig. 6 ). We wondered whether the silencing of the locus is intrinsic to reprogramming, and therefore whether it occurs even under conditions in which the locus is not functional. To test this, we performed three-factor-reprogramming in MEFs previously infected with a retrovirus expressing SV40 large-T (MEF-LT cells). Cells carrying SV40 large-T lack functional Rb and p53, rendering the Ink4/Arf locus functionally irrelevant despite its high levels of expression 12 . Interestingly, the high levels of expression of the Ink4/Arf locus in MEF-LT cells began to decrease soon (day 3) after introduction of the three factors ( Fig. 2c and Supplementary  Fig. 7 ). These observations dissociate the silencing of the Ink4/Arf locus from its anti-proliferative capacity, and suggest that three-factorreprogramming, rather than selecting rare pre-existing cells with a silent Ink4/Arf locus, enforces a process that includes the silencing of the Ink4/Arf locus regardless of its functionality.
Next, we wondered whether the silencing of the Ink4/Arf locus was rate-limiting for reprogramming. For this, we scored the 'yield' of alkaline-phosphatase-positive colonies between days 10 and 12, when colonies are first visible. The yield of colonies was corrected by the efficiency of retroviral infection measured in parallel infections with the three factors plus green fluorescence protein (GFP), all at equal proportions (see Methods). The efficiency of three-factorreprogramming in a series (n 5 10) of independent wild-type MEF cultures was 0.54% 6 0.26 (mean 6 s.d.) (see primary data in Supplementary Table 1 ). MEFs deficient in Ink4a/Arf were reprogrammed with an efficiency that was on average 15-fold higher than in wild-type MEFs ( Fig. 3a and Supplementary Fig. 8 ). We confirmed the functionality of the Ink4a/Arf-null iPS cells by demonstrating that they are chromosomally stable ( Supplementary  Fig. 9 ), produce teratomas with representation of the three developmental layers ( Supplementary Fig. 10 ), and generate chimaeras ( Supplementary Fig. 11 ). Deficiency of Arf alone also increased reprogramming efficiency by a factor of sevenfold, an effect that was quantitatively similar to that observed in p53-null MEFs (Fig. 3a) , which is in agreement with the concept that p53 is the main target of Arf 13 and also with previous data indicating that p53 inhibition increases reprogramming 14 . The cell-cycle inhibitor p21 mediates part, but not all, of the anti-proliferative effects of p53 (ref. 15) , and interestingly, reprogramming efficiency increased by a factor of fourfold in p21-null MEFs (Fig. 3a) . Addition of c-Myc to the reprogramming cocktail (four-factor-reprogramming) improved the reprogramming efficiency of wild-type MEFs, and the absence of Ink4a/Arf still had a clear positive effect on reprogramming (Fig. 3a) . To prove further the implication of Ink4a and Arf on reprogramming, we performed assays in wild-type cells adding to the three factors a retrovirus expressing a short hairpin RNA (shRNA) against Ink4a (targeted to exon 1a), Arf (to exon 1b), or both (to the common exon 3) (see Supplementary Fig. 1) . Notably, the single inhibition of Ink4a LETTERS or Arf had a beneficial effect on reprogramming, which was more prominent in the case of Arf shRNA ( Fig. 3b and Supplementary  Fig. 12a ). Simultaneous inhibition of Ink4a and Arf had the maximal effect, close to that observed in cells genetically null for these genes (Fig. 4a, b ). In agreement with the concept that retroviral vectors are only transiently expressed during reprogramming and then become permanently silenced in iPS/ES cells 16 , we observed that after retinoicacid differentiation of Ink4a/Arf shRNA iPS cells, the levels of expression of Ink4a and Arf were normally induced ( Supplementary Fig. 12b ).
Furthermore, we wanted to extend the earlier observations to cell types other than fibroblasts. Remarkably, when using mouse keratinocytes from newborn mice, the absence of Ink4a/Arf increased the yield of iPS cell colonies more than 100-fold, and, as in the case of MEFs, the absence of Ink4a/Arf had a more pronounced effect than the absence of p53 (Fig. 3c) .
In addition to the effect of the Ink4/Arf locus on the yield of iPS cell colonies, we noted that Ink4/Arf-null iPS cell colonies appear significantly faster than wild-type iPS cell colonies. For example, at day 7, wild-type MEFs showed 'pre-iPS cell' micro-colonies characterized by being flat, lacking smooth borders, and having cells with a fibroblast morphology (Fig. 3e) ; in contrast, Ink4a/Arf-null MEFs at this time already presented colonies with bona fide iPS/ES cell morphology (Fig. 3e) . To document this further, we observed that the early reprogramming markers alkaline phosphatase and SSEA1 (refs 17, 18) appear earlier in Ink4a/Arf-null MEFs compared to wild-type MEFs, with alkaline phosphatase being detectable as early as day 3 (Fig. 3d) . Notably, in wild-type MEFs, the appearance of alkaline phosphatase and SSEA1 occurred after day 4, and this timing is coincident with our first detectable evidence of repression of the locus by the three factors (see Fig. 2 ). A summary of these data is shown in Fig. 3f . The faster kinetics of reprogramming of Ink4a/Arf-null MEFs can be due, at least in part, to their faster proliferation rate during the initial stages of reprogramming ( Supplementary Fig. 13a ). Once reprogramming is completed, both wild-type iPS cells and Ink4a/ Arf-null iPS cells proliferate at similar rates ( Supplementary Fig.  13b ), in agreement with the fact that wild-type iPS cells have a silent Ink4/Arf locus. We conclude that inhibition of the Ink4/Arf locus has a dual effect on reprogramming: accelerating the process and also increasing the number of successfully reprogrammed cells. We extended the earlier concepts to the reprogramming of human cells. In particular, we performed three-and four-factor-reprogramming of 'telomerized' human IMR90 fibroblast cells, carrying ectopically expressed human TERT (IMR90-TERT). Interestingly, supplementation of three or four factors with a retrovirus expressing INK4a shRNA had a positive effect on the efficiency of reprogramming (Fig. 3g) . In contrast, ARF shRNA had no effect on the reprogramming of human fibroblasts (Fig. 3g) , which is in agreement with the modest role of ARF in these cells 19 . The human INK4a shRNA iPS cells expressed endogenous SOX2, NANOG, alkaline phosphatase and SSEA3, and formed teratomas (Supplementary Figs 14 and  15) . When comparing the human and mouse data, a theme emerges that is extensively reported in other biological contexts 20 , namely, that Arf dominates over Ink4a in murine cells, whereas INK4a dominates over ARF in human cells.
Ink4a Ink4b Arf
The expression of the Ink4/Arf locus is progressively upregulated at old age 2, 5 . On the basis of this, we proposed that ageing should decrease reprogramming efficiency and that this should be rescued, at least in part, by inhibition of the locus. Murine skin fibroblasts (MSFs) from ear punches of old ($2 years) mice had a significantly increased expression of the locus compared to MSFs from young (2 months) mice, and this was accompanied by a lower reprogramming efficiency of the old MSFs (Fig. 4a, b) . Notably, the addition of Ink4a/Arf shRNA to the old MSFs rescued their low reprogramming efficiency to the same levels as young MSFs (Fig. 4b) , thus suggesting that the Ink4/Arf locus is partly responsible for the decreased reprogramming associated with ageing.
Collectively, our data indicate that the Ink4/Arf locus constitutes a main barrier to reprogramming in different cell types (fibroblasts and keratinocytes) and in different species (mouse and human). Experimental inhibition of the Ink4/Arf locus improves reprogramming efficiency, both accelerating the process and increasing the number of successfully reprogrammed cells. Also, transitory inhibition of the locus could be of particular practical advantage when reprogramming cells from aged individuals. Finally, recent data have pointed out similarities between malignant cells and embryonic stem cells 21, 22 and, in this context, there is a parallelism between the known activity of Ink4/Arf locus as a barrier to malignancy and the new activity reported here as a barrier to de-differentiation.
METHODS SUMMARY
Primary MEFs were reprogrammed following modifications of a previous protocol 23 . Human fibroblasts were reprogrammed as previously described 24, 25 . For quantification of iPS cell generation efficiency, retroviral transduction was measured in parallel infections containing the reprogramming factors plus a GFP retroviral plasmid, followed by FACS analysis at day 3 (see day numbering at Fig. 2a) . The total number of iPS cell colonies was counted after staining plates for alkaline phosphatase activity (AP detection kit, Chemicon International) following the manufacturer's instructions. All statistical analyses correspond to unpaired two-tailed Student's t-tests.
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature.
METHODS
Culture conditions. Primary MEFs (passage 2) and keratinocytes of the indicated genotypes were obtained from pure inbred C57BL/6 background mice, as described previously 26, 27 . MSFs were obtained from the ears of young (2 months) or old (2 years) wild type C57BL/6 mice as described before 28 . Primary murine fibroblasts (MEFs and MSFs) were cultured in standard DMEM medium with 10% FBS (Gibco). Murine keratinocytes were cultured in basal keratinocyte medium (CellNTec). Human foreskin fibroblasts IMR90 stably expressing TERT (IMR90-TERT) were cultured in standard DMEM medium with 10% FBS. Murine ES and iPS cells were cultured in 'complete KSR medium' composed of DMEM (high glucose) supplemented with serum replacement (KSR, 15%, Invitrogen), LIF (1,000 U ml 21 ), non-essential amino acids, glutamax and b-mercaptoethanol. C57BL/6 ES cells were derived at the Transgenic Mice Unit of the CNIO from C57BL/6 blastocysts. Human iPS cells were cultured in 'human ES medium' composed of DMEM/F12 supplemented with serum replacement (KSR, 20%, Invitrogen), non-essential amino acids, glutamax, b-mercaptoethanol and bFGF (4 ng ml 21 ). Generation of mouse iPS cells. Reprogramming of primary (passage 2-4) MEFs was performed following modifications of a previous protocol 23 . In brief, retroviral supernatants were produced in HEK-293T cells (5 3 10 6 cells per 100-mmdiameter dish) transfected with the ecotropic packaging plasmid pCL-Eco (4 mg) together with one of the following retroviral constructs (4 mg): pMXs-Klf4, pMXs-Sox2, pMXs-Oct4 or pMXs-c-Myc (obtained from Addgene and previously described 1 ). The retroviral vector expressing mouse shRNA against Ink4a, Arf and Ink4a/Arf, and the corresponding empty vector LMP were provided by S. Lowe 29 . Transfections were performed using Fugene-6 transfection reagent (Roche) according to the manufacturer's protocol. Two days later, retroviral supernatants (10 ml) were collected serially during the subsequent 48 h, at 12-h intervals, each time adding fresh medium to the cells (10 ml). The recipient MEFs had been seeded the previous day (2.5 3 10 5 cells per 100-mm-diameter dish) and received 1.5 ml of each of the corresponding retroviral supernatants (amounting in the case of the three factors to 4.5 ml, and in the cases of the three factors plus shRNA or the four factors to 6 ml, and in the case of the four factors plus shRNA to 7.5 ml). This procedure was repeated every 12 h for 2 days (a total of four additions). After infection was completed, medium was replaced by complete KSR medium (see earlier). Cultures were maintained in the absence of drug selection with daily medium changes 23 . From days 10 to 12 (according to the day numbering in Fig. 2a) , colonies with ES-cell-like morphology became visible and were scored after alkaline phosphatase staining. Colonies were picked at day 14 and expanded on feeder fibroblasts using standard procedures.
For reprogramming of murine keratinocytes, cells were freshly isolated from neonates (days 1-4 post-partum) 27 , and were reprogrammed at passage 5. Virus was produced in HEK-293T cells as described earlier, and 3 3 10 5 keratinocytes were plated per 60-mm collagen-coated plate. On the 2 days after cell seeding, infections were performed twice daily. The keratinocytes were exposed to the cocktail of viral supernatants for 1-h intervals to prevent differentiation and then allowed to recover in basal keratinocyte media (CellNTec) between infections. The day after infection, media were changed to a 'mixture medium' containing basal keratinocyte medium supplemented with serum replacement (KSR, 15%, Invitrogen), LIF (1,000 U ml 21 ), non-essential amino acids, glutamax and b-mercaptoethanol. Medium was changed daily and cellular changes in plates were monitored. Clones were picked and amplified in conventional complete KSR medium. Generation of human iPS cells. Reprogramming of IMR90-TERT cells was done as previously described 24, 25 . In brief, retroviral supernatants were produced in HEK-293T cells (5 3 10 6 cells per 100-mm-diameter dish) transfected with the ecotropic packaging plasmid pCL-Ampho (4 mg) together with one of the following retroviral constructs (4 mg): pMXs-hKlf4, pMXs-hSox2, pMXs-hOct4 and pMXs-hc-Myc (obtained from Addgene and previously described 24 ). The retroviral vectors expressing human shRNA pRetroSuper-ARF and pRetroSuper-INK4a were provided by R. Agami 30 . Transfections and infections were performed the same as mouse iPS cell reprogramming described earlier. IMR90-TERT fibroblasts had been seeded the previous day (2 3 10 5 cells per well in 6-well gelatin-coated plates) and received 1.5 ml of each of the corresponding retroviral supernatants (either a total of three or four-the fourth factor being the INK4a shRNA or ARF shRNA, see later). This procedure was repeated every 12 h for 2 days (a total of four additions). The day after infection was completed, medium was replaced, and kept for three more days (days 2, 3 and 4, according to the numbering scheme in Fig. 2a) . At day 5, cells were trypsinized and reseeded on feeder plates. At day 6, medium was changed to human ES cell medium. Cultures were maintained in the absence of drug selection with daily medium changes. At day 17, colonies with ES-cell-like morphology became visible at the microscope. Colonies were picked after 3 weeks and expanded on feeder fibroblasts using standard procedures.
Reprogramming efficiency. For quantification of iPS cell generation efficiency, retroviral transduction was measured in parallel infections containing all the retroviruses used for reprogramming plus a GFP retrovirus (pBabe-PURO-GFP) (equal volumes of each retrovirus). The efficiency of infection was measured by FACS analysis at day 3 (see day numbering in Fig. 2a) . The total number of iPS cell colonies was counted after staining plates for alkaline phosphatase activity (AP detection kit, Chemicon International) following the manufacturer's instructions. Chimaera formation. The capacity of the iPS cell clones to generate chimaeras in vivo was tested by microinjection into C57BL/6J-Tyr C-2J /J (albino) blastocysts, or by aggregation with CD1 (albino) morulae. Differentiation with retinoic acid. Differentiation with retinoic acid was performed essentially as described 10 . Cultures were grown to near confluency in complete KSR medium with LIF (day 0), and then trypsinized and seeded at a lower density in the absence of LIF for 1 day (day 1). During the next 2 days (days 2 and 3), retinoic acid was added at a concentration of 10 26 M. Teratoma formation. Ink4/Arf-null (three factors) iPS cells or human iPS cells (four factors plus INK4a shRNA, or four factors plus INK4a shRNA and ARF shRNA) (2 3 10 6 cells) were subcutaneously injected into irradiated (4 Gy) nude mice (injections were performed 1 day after irradiation). Teratomas were surgically removed after 3 weeks in the case of murine iPS cells, or after 9 weeks in the case of human iPS cells. Tissue was fixed in formalin at 4 uC, embedded in paraffin wax, and sectioned at a thickness of 5 mm. Sections were stained with haematoxylin and eosin for pathological examination, or processed for immunohistochemical analysis with antibodies against mouse p19
Arf (SantaCruz 5-C3-1) or for markers of differentiation. In the case of murine teratomas: anti-neuronal nuclei (NeuN, MAB377, Chemicon) for neuroectoderm, cytokeratin-19 (CK-19, Developmental Studies Hybridoma Bank) for ectoderm, common-muscle actin (HHF-35, M0635, Dako) for mesoderm, and chymotrypsin (2100-0657, Serotec) for endoderm. In the case of human teratomas: synaptophysin (SY38 Dako) for ectoderm marker), smooth muscle actin (SMA, 1A4, Dako) for mesoderm, and cytokeratins (AE1/AE3, Dako) for endoderm. Quantitative real-time PCR. Total RNA from cells was extracted with Trizol (Life Technologies). Samples were treated with DNase I before reverse transcription using random priming and Superscript Reverse Transcriptase (Life Technologies), according to the manufacturer's protocols. Quantitative realtime PCR was performed using an ABI PRISM 7700 (Applied Biosystems), using DNA Master SYBR Green I mix (Applied Biosystems). All values were obtained at least in duplicate, and in a total of at least two independent assays. The primers used were: mInk4a-F, 59-CGTACCCCGATTCAGGTGAT-39; mInk4a-R 59-TTGAGCAGAAGAGCTGCTACGT-39; mInk4b-F, 59-AGATCCC AACGCCCTGAAC-39; mInk4b-R, 59-CCCATCATCATGACCTGGATT-39; mArf-F, 59-GCCGCACCGGAATCCT-39; mArf-R, 59-TTGAGCAGAAGAGCT GCTACGT-39; mp21-F, 59-GTGGGTCTGACTCCAGCCC-39; mp21-R, 59-CC TTCTCGTGAGACGCTTAC-39; mNanog-F, 59-AGGGTCTGCTACTGAGATG CTCTG-39; mNanog-R, 59-CAACCACTGGTTTTTCTGCCACCG-39; mEsg1-F, 59-GAAGTCTGGTTCCTTGGCAGGATG-39; mEsg1-R, 59-ACTCGATACAC TGGCCTAGC-39; Gapdh-F, 59-TTCACCACCATGGAGAAGGC-39; Gapdh-R, 59-CCCTTTTGGCTCCACCCT-39; hEndo-SOX2-F, 59-GGGAAATGGGAG GGGTGCAAAAGAGG-39; hEndo-SOX2-R, 59-TTGCGTGAGTGTGGATG GGATTGGTG-39; hNANOG-F, 59-TTTCAGAGACAGAAATACCTCAGC-39; hNANOG-R, 59-TCACACCATTGCTATTCTTCG-39; hACTB-F, 59-CAAGGCC AACCGCGAGAAGAT-39; and hACTB-R, 59-CCAGAGGCGTACAGGGA TAGCAC-39. Calculations for the values were made using the DDC t method, as previously described 31 . FACS. FACS was performed as previously described 17 . In brief, cells were trypsinized and washed once in PBS. For APC-conjugated SSEA1 (R&D), 1 3 10 5 cells were washed once in PBS and 0.5% BSA, and incubated with 10 ml of SSEA1 in 50 ml of PBS, 0.5% BSA for 30 min at 4 uC. Afterwards, cells were washed by PBS and 0.5% BSA once to remove antibody, and resuspended in 300 ml PBS for FACS analysis. For alkaline phosphatase staining, cells were washed once in PBS and fixed/permeabilized using an intracellular staining kit (eBioscience). After permeabilization, cells were treated with 500 ml of alkaline phosphatase substrate (Vector Red substrate kit, Vector Laboratories) and stained according to the manufacturer's protocol for 20 min. Cells were washed once and resuspended in PBS for FACS analysis. FACSCanto II (BD Biosciences) was used for all FACS analysis. Mock-infected cells were stained and analysed in parallel to set the thresholds. Western blot. Cell extracts were prepared using RIPA buffer, resolved on NuPAGE 4-12% gradient Bis-Tris gels, transferred to nitrocellulose and hybridized using antibodies against Oct4 (1:250; H-134, SantaCruz), Sox2 (1:250; ab5603, Chemicon) and Klf4 (1:250; SantaCruz). Immunofluorescence. MEF-LT cells were grown on chamber slides and infected with or without the three factors using the same reprogramming protocol as for the rest of the experiments. At days 3 and 8, cells were fixed with 2% paraformaldehyde for 15 min at room temperature, washed with PBS and permeabilized with PBS containing 0.02% Tween-20 for 20 min. Cells were blocked in PBS with 4% BSA for 1 h and incubated with antibodies against mouse p19
Arf (SantaCruz; 1:250 in PBS and 4% BSA) for 2 h, washed with PBS and further incubated with secondary antirat antibodies conjugated with Cy3 (1:1,000 in PBS and 4% BSA). For NANOG immunofluorescence of human iPS cells, cells were seeded in 2-well chamber slides with feeders, fixed in 4% paraformaldehyde for 15 min, permeabilized (PBS and 0.1% Triton X-100) for 15 min and blocked (PBS and 5% BSA) for 1 h at room temperature. NANOG antibody (1:500; Chemicon) was added and incubated in PBS and 2% BSA overnight. The next day, cells were washed by PBS and incubated with Alexa Fluor 488 secondary antibodies against mouse (1:1,000 in PBS and 4% BSA). For SSEA3 immunofluorescence of human iPS cells, cells were grown on 6-well plates with feeders, and fixed with 4% paraformaldehyde for 15 min at room temperature. Wells were washed with PBS before blocking in PBS with 4% BSA for 1 h and incubated with antibody against human SSEA3 (R&D, 25 mg ml 21
